维普期刊资源整合服务平台（V6.5）

35篇 您的检索式：作者名="Rubagotti F"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Switching toanastrozole versus continue oxifen treatment of early breastcancer: preliminary results of the Italian oxifen anatrozoletrial 显示文摘	Boccardo F Rubagotti A Punyoni M	2005	Clin Oncol2005，23，：	1
2	Nuclear matrix pro- teins changes in cancerous prostate tissues and their prognostic value in clinically localized prostate cancer 显示文摘	Boccardo F Rubagotti A Carmignani G	2003	Prostate2003，55，4：	1
3	Cyclophospharnide,methotrexate,and fluorouracil versus tamoxifen plus ovarian suppression as adjuvant treatment of estrogen receptor- positive pre -/perimenopausal breast cancer patients: results of the Italian breast cancer adjuvant study group 02 randomized trial显示文摘	Rubagotti A Amoroso D	2000	J Clin Onco12000，18，14：	1
4	Cyclophosphamide,methotrexate, and fluorouracil versus tamoxifen plus ovarian suppression as adjuvant treatment of estrogen receptor-positive pre-/perimenopausal breast cancer patients:results of the Italian Breast Cancer Adjuvant Study Group 02 randomized trial显示文摘	Rubagotti A Amorosos D	2000	J Clin Oncol2000，18，14：	1
5	Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial显示文摘	Boccardo F Rubagotti A Puntoni M	2005	J Clin Oncol2005，23，22：	1
6	Nuclear matrix proteins changes in cancerous prostate tissues and their prognostic value in clinically localized prostate can- cer 显示文摘	Boccardo F Rubagotti A Carmignani G	2003	Prostate2003，55，4：	1
7	Ovarian ablation versus goserelin with or without tamoxifen in pre-/perimenopausal patients with advanced breast cancer:results of a multicentric Italian study显示文摘	BOCCARDO F RUBAGOTTI A PERROTTA A	1994	Ann Oncol1994，5，4：	1
8	Switching to anastrozole versus continued tamoxifen treatment of early breast cancer ; preliminary results of the Italian Tamoxifen Anastrozde Trial 显示文摘	Boccardo F Rubagotti A Puntoni M	2005	J clin Oncol2005，23，22：	1
9	Ovarian ablation versus goserelin with or without tamoxifen in per-perimenopausal patient with advanced breast cancer: result of a multicentric Italy study显示文摘	Rubagotti R Perotta	1994	Ann Oncol1994，5，33：	1
10	Exploratory study ofdrug plasma levels during bicalutamide 150 mg therapy co-admi-nistered with tamoxifen or anastrozole for prophylaxis of gyne-comastia and breast pain in men with prostate cancer显示文摘	Boccardo F Rubagotti A Conti G	2005	CancerChemother Pharmacol2005，56，4：	1
11	A cellular automata based model for pedestrian and group dynamics: Motivations and first experiments显示文摘	Bandini S Rubagotti F Vizzari G	2011	Parallel Computing Technologies2011，，：	1
12	Prednisone plus gefitinib versus prednisone plus placebo in the treatment of hormone-refractory prostate cancer: a randomized phase II trial 显示文摘	Boccardo F Rubagotti A Conti G	2008	Oneology2008，74，34：	1
13	Switching to anastrozole versus continued tamoxifen treatment of early breast cancer:preliminary results of the Italian Tamoxifen Anastrozole Trial显示文摘	Boccardo F Rubagotti A Puntoni M	2005	J Clin Oncol2005，23，：	1
14	Ovarian ablation versus goserelin with or without tamoxifen in pre- perimenopausal patients with advanced breast cancer; results of amulticentric italian study显示文摘	Bocea F Rubagotti A Perrotta A	1994	Ann Oncol1994，5，：	1
15	Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer patients:results of an Italian Prostate Cancer Project study显示文摘	Rubagotti A Barichello M	2002	European Urology2002，42，5：	1
16	Cyclophosphamide,methotrexate,and fluorouracil versus tamoxifen plus ovarian suppression as adjuvant treatment of estrogen receptor-positive pre/permenopausal breast cancer patients:result of the Italian Breast Cancer Adjuvant Study Group 02 Randomized Trial显示文摘	Boccardo F Rubagotti A Amoroso D	2000	J Clin Oncol2000，18，14：	1
17	Ovarian ab- lation versus goserelin with or without tamoxifen in pre- and perimenopausal patients with advanced breast cancer: results of a multicentric Italian study显示文摘	Boccardo F Rubagotti A Perrotta A	1994	Ann Oncol1994，5，4：	1
18	Switching to anastrozole versus continued tamoxifen treatment of early breast cancer:preliminary results of the Italian Tamoxifen Anastrozole Trial显示文摘	Boccardo F Rubagotti A Puntoni M	2005	Journal of Clinical Oncology2005，23，22：	1
19	Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma: pooled analysis of 2 consecutive trials显示文摘	Boccardo F Rubagotti A Aldrighetti D	2007	Cancer2007，109，6：	1
20	Switching to anastrozole versus continued tamoxifen treatment of early breast cancer:preliminary results of the ltalian Tamoxifen Anastrozole Trial显示文摘	Boccardo F Rubagotti A Puntoni M	2005	J Clin Oncol2005，23，22：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示